Monitazone Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Mometasone furoate

Indications/Uses

Symptomatic treatment & prophylaxis of seasonal allergic rhinitis. Treatment of perennial allergic rhinitis in adults & ped patients ≥2 yr. Nasal polyps in patients ≥18 yr. Adjunctive treatment to antibiotic in patients ≥12 yr w/ acute sinusitis episode.

Click to view Monitazone detailed prescribing information

Dosage/Direction for Use

Allergic rhinitis Adult (including geriatric patient) & childn ≥12 yr 2 sprays in each nostril once daily, dose may be reduced to 1 spray in each nostril once symptom is controlled. May be increased to max: 4 sprays in each nostril once daily, 2-11 yr 1 spray in each nostril once daily. Nasal polyp 2 sprays in each nostril once daily, may be increased to max: 2 sprays in each nostril bd if symptoms are inadequately controlled after 5-6 wk. Acute sinusitis episode 2 sprays in each nostril bd.

Click to view Monitazone detailed prescribing information

Overdosage

View Monitazone overdosage for action to be taken in the event of an overdose.

Contraindications

Hypersensitivity. Not to be used in presence of untreated localised infection involving nasal mucosa & recent nasal surgery or trauma.

Click to view Monitazone detailed prescribing information

Special Precautions

Discontinue use if localized nose or pharynx fungal infection develops. Active or quiescent tuberculous resp tract infection or untreated fungal, bacterial, systemic viral infections or ocular herpes simplex. Immunosuppressed patients. W/drawal symptoms during transfer from systemic corticosteroids. Long-term use. Not to be used during pregnancy & lactation.

Click to view Monitazone detailed prescribing information

Use In Pregnancy & Lactation

Click to view Monitazone detailed prescribing information

Adverse Reactions

Headache; viral infection; pharyngitis; epistaxis/blood-tinged mucus; coughing; pharyngitis, upper resp tract infection; dysmenorrhea; musculoskeletal pain; sinusitis; vomit.

Click to view Monitazone detailed prescribing information

Drug Interactions

Increased plasma conc w/ ketoconazole.

Click to view Monitazone detailed prescribing information

Caution For Usage

For caution against possible variation of physical aspect of medicine... Click to view Monitazone detailed prescribing information

Storage

View Monitazone storage conditions for details to ensure optimal shelf-life.

Description

View Monitazone description for details of the chemical structure and excipients (inactive components).

Action

View Monitazone mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Nasal Decongestants & Other Nasal Preparations

ATC Classification

D07AC13 - mometasone ; Belongs to the class of potent (group III) corticosteroids. Used in the treatment of dermatological diseases.

Regulatory Classification

POM

Presentation/Packing

Form

Monitazone nasal spray 0.5 mg/mL

Packing/Price

140 spray x 1's

Monitazone

mometasone

Manufacturer:

Ildong

Distributor:

KTZ